logo

Research

Help: To find Illnesses or Conditions associated with a Herbal Remedy. Select a letter from A - Z of Herbal Remedies. Or Scroll lists. Or Use Search.

Hawthorn Remedy


Hawthorn - Herbal Research

A WHO Organization resource Hawthorn - FULL REPORT


Medicinal uses supported by clinical data
 
Treatment of chronic congestive heart failure stage II, as defined by the New York Heart Association (24-34).
 
Uses described in pharmacopoeias and in traditional systems of medicine
 
Support of cardiac and circulatory functions (35).
 
Uses described in folk medicine, not supported by experimental or clinical data
 
As an antispasmodic agent in the treatment of asthma, diarrhoea, gall bladder disease and uterine contractions, and as a sedative for the treatment of insomnia (5).
 
References:
5. Farnsworth NR, ed. NAPRALERT database. Chicago, University of Illinois at Chicago, IL, February 9, 1998 production (an online database available directly through the University of Illinois at Chicago or through the Scientific and Technical Network [STN] of Chemical Abstracts Services).
 
24. American Heart Association Medical/Scientific Statement. 1994 revisions to classi- fication of functional capacity and objective assessment of patients with heart diseases. Circulation, 1994, 90:644-645.
 
25. Bödigheimer K, Chase D. Wirksamkeit von Weissdorn-Extrakt in der Dosierung 3 × 100 mg täglich. Multizentrische Doppelblind-Studie mit 85 herzinsuffizienten Patienten im Stadium NYHA II. Münchener Medizinische Wochenschrift, 1994, 136 (Suppl. 1):18-21.
 
26. Eichstädt H et al. Crataegus-Extrakt hilft dem Patienten mit NYHA-II Herzinsuf- fizienz. Untersuchung der myokardialen und hämodynamischen Wirkung eines standardisierten Crataegus-Präparates mit Hilfe computergestützter Radionuklidventrikulographie. Therapiewoche, 1989, 39:3288-3296.
 
27. Förster A et al. Crataegus bei mässig reduzierter linksventrikulärer Auswurffraktion. Münchener Medizinische Wochenschrift, 1994, 136 (Suppl. 1):21-26.
 
28. Leuchtgens H. Crataegus-Spezialextrakt WS 1442 bei Herzinsuffizienz NYHA II. Fortschritte der Medizin, 1993, 111:352-354.
 
29. Loew D. Crataegus-Spezialextrakte bei Herzinsuffizienz. Gesicherte pharmakologische und klinische Ergebnisse. Der Kassenarzt, 1994, 15:43-52.
 
30. Loew D. Phytotherapy in heart failure. Phytomedicine, 1997, 4:267-271.
 
31. Schmidt U et al. Effect of hawthorne (Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as NYHA functional class II. Phytomedicine, 1994, 1:17-24.
 
32. Tauchert M et al. Wirksamkeit des Weissdorn-Extraktes LI 132 im Vergleich mit Captopril. Münchener Medizinische Wochenschrift, 1994, 136 (Suppl. 1):27-33.
 
33. Weikl A, Noh HS. Der Einfluss von Crataegus bei globaler Herzinsuffizienz. Herz und Gefässe, 1992:516-524.
 
34. Weikl A et al. Crataegus-Spezialextrakt WS 1442. Fortschritte der Medizin, 1996, 114:291-296.
 
35. Wichtl M. Crataegi folium cum flore. In: Wichtl, M ed. Teedrogen und Phytopharmaka, 3rd ed. Stuttgart, Wissenschaftliche Verlagsgesellschaft, 1997:168-172.
 


Health Issues

UK-based trade group the Health Food Manufacturers Association (HFMA) has written a formal letter of complaint to the BBC about a controversial BBC2 Horizon programme about the food supplements industry.

VIEW MORE

Consumers are demanding BPA-free products, but the alternatives are no safer. Despite this alarming data, nearly 81% of Americans have detectable levels of BPS in their urine.

VIEW MORE

Widely promoted as a ‘safe’ and ‘healthy’ alternative way to quit smoking, the adoption of vaping has grown exponentially in recent years.

VIEW MORE